Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.45 - $91.58 $43,470 - $54,948
600 Added 3.09%
20,000 $1.61 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $3.39 Million - $4.06 Million
-41,700 Reduced 68.25%
19,400 $1.6 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $2.22 Million - $2.65 Million
31,100 Added 103.67%
61,100 $5.21 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $2.48 Million - $2.85 Million
-30,800 Reduced 50.66%
30,000 $2.57 Million
Q3 2023

Nov 09, 2023

BUY
$82.56 - $93.49 $5.01 Million - $5.68 Million
60,722 Added 77848.72%
60,800 $5.45 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $6,305 - $6,977
78 New
78 $6,000
Q1 2022

May 13, 2022

SELL
$43.77 - $63.22 $1,575 - $2,275
-36 Reduced 36.0%
64 $4,000
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $4,013 - $6,041
81 Added 426.32%
100 $5,000
Q3 2021

Nov 04, 2021

BUY
$57.6 - $70.59 $1,094 - $1,341
19 New
19 $1,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.21B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.